Abdominal pain with diarrhea 6 episodes/day for 2 days
"acute diarrhea" AND "management" AND "adult"
"acute diarrhea" AND treatment
PMID: 35839362
| Feature | Implication |
|---|---|
| Bloody or mucoid stool | Suggests invasive/inflammatory pathogen - avoid loperamide, consider antibiotics |
| Fever >38.5°C | Inflammatory diarrhea; stool cultures warranted |
| Signs of dehydration (orthostasis, decreased urine output, dry mucosae) | IV fluids may be needed |
| Severe abdominal pain | Consider surgical cause, C. diff, ischemic colitis |
| Diarrhea >7 days without improvement | Broadens differential (parasitic, IBD) |
| Recent antibiotics (<8 weeks) | C. difficile must be excluded |
| Recent travel (especially to endemic areas) | Travelers' diarrhea, parasites |
| Immunocompromised | Aggressive workup warranted |
| Component | WHO ORS Composition |
|---|---|
| Sodium | 75 mmol/L |
| Glucose | 75 mmol/L |
| Potassium | 20 mmol/L |
| Chloride | 65 mmol/L |
| Citrate | 10 mmol/L |
| Indication | Preferred Regimen |
|---|---|
| Suspected sepsis | Empiric broad-spectrum (IV) |
| Travelers' diarrhea (moderate-severe) | Azithromycin 1 g PO x1 (preferred); Rifaximin 200 mg TID x3 days (non-invasive, no fever); Ciprofloxacin 500 mg q12h x3 days (increasing resistance) |
| Confirmed Shigella | Azithromycin or ciprofloxacin x3-5 days |
| Confirmed Campylobacter (severe) | Azithromycin 500 mg/day x3 days |
| Confirmed C. difficile | Fidaxomicin 200 mg BID x10 days (preferred) or oral vancomycin 125 mg QID x10 days |
| Confirmed Giardia | Metronidazole 250 mg TID x5-7 days |
Acute watery diarrhea x2 days, 6 episodes/day, healthy adult
|
Red flags? (blood, fever, recent antibiotics, travel, immunocompromised)
/ \
YES NO
| |
Stool testing Clinical diagnosis (viral gastroenteritis)
Targeted Rx Supportive care only:
- ORS / oral fluids
- Loperamide if watery/non-bloody
- BRAT diet, avoid dairy
- Reassess if >7 days
Treatment for cracked soles
"heel fissures" OR "cracked heels" treatment
PMID: 34090765
cracked heels heel fissures treatment urea emollients clinical management
https://www.austinpublishinggroup.com/dermatology/fulltext/a…
| Grade | Description | Management Level |
|---|---|---|
| Grade I (Superficial) | Dry, flaking skin; no visible crack depth | OTC emollients + exfoliation |
| Grade II (Moderate) | Partial-thickness fissures into dermis; pain on walking | Keratolytics + occlusion |
| Grade III (Severe) | Full-thickness splits; bleeding, infection risk | Wound care + possible procedural treatment |
| Agent | Concentration | Notes |
|---|---|---|
| Urea cream | 20-40% | Gold standard; 40% is prescription-strength; aggressive keratolysis for thick callus |
| Lactic acid / ammonium lactate | 5-12% | Comparable efficacy to urea; better cosmetic feel; use if urea causes irritation |
| Salicylic acid | 6-17% (in combination products) | Keratolytic; found in products like Kerasal; AMPA-approved for heel fissures |
| Urea + lactic acid combination | - | Synergistic - urea penetrates deep, lactic acid promotes surface turnover |
What to look for ESR and CRP in fevee
| Feature | ESR | CRP |
|---|---|---|
| What it measures | Rate of fall of RBCs in 1 hour - indirect reflection of fibrinogen, globulins | Single acute-phase protein synthesized by hepatocytes |
| Normal | Men: age ÷ 2 mm/h; Women: (age + 10) ÷ 2 mm/h | <0.3 mg/dL (most healthy adults) |
| Rise after stimulus | Slow - peaks over days to weeks | Rapid - rises within 6-12 hours, peaks at 2-3 days |
| Fall after resolution | Slow (weeks) | Rapid - half-life ~19 hours; clears fast when inflammation resolves |
| Age/sex effect | Higher in women and elderly | Not significantly affected by age or sex |
| Precision | Lower - affected by many variables | Higher - precise, reproducible, measurable on stored sera |
| ESR Level | Interpretation in Fever |
|---|---|
| Mildly elevated (up to ~40 mm/h) | Often non-specific; viral illness, minor inflammation |
| Moderately elevated (40-70 mm/h) | Warrants workup; infection, autoimmune, malignancy possible |
| Markedly elevated (>100 mm/h) | Strongly suggests serious disease - bacterial infection, temporal arteritis/PMR, malignancy (multiple myeloma, lymphoma), or major autoimmune disease |
Key point: An ESR >100 mm/h almost always has an identifiable serious cause - the underlying diagnosis is usually apparent from history and physical, especially at extreme levels. If no cause is found, repeat in months rather than initiating a blind workup. - Textbook of Family Medicine, 9e
| CRP Level | Clinical Interpretation |
|---|---|
| <1 mg/dL (minor/normal) | Vigorous exercise, common cold, pregnancy, gingivitis, obesity, depression, insulin resistance |
| 1-10 mg/dL (moderate) | Myocardial infarction, malignancies, pancreatitis, mucosal infections (bronchitis, cystitis), most systemic autoimmune diseases (RA, IBD) |
| >10 mg/dL (marked) | Acute bacterial infection (80-85% of cases), major trauma, systemic vasculitis |
| >15 mg/dL | Strongly suggests bacterial infection |
| >50 mg/dL | Infection present in 88% of cases |
Critical rule: CRP >10 mg/dL = bacterial infection until proven otherwise. - Firestein & Kelley's Rheumatology

| Clinical scenario | What to expect |
|---|---|
| Viral fever | ESR mildly elevated, CRP low-to-moderate (<5 mg/dL) |
| Bacterial infection | CRP markedly elevated (>10 mg/dL), ESR also elevated but lags |
| Autoimmune flare (RA, vasculitis) | Both elevated; CRP 1-10+ mg/dL depending on disease |
| Lupus flare | ESR elevated, CRP normal or only mildly elevated |
| Malignancy (lymphoma, myeloma) | ESR markedly elevated; CRP variable |
| Resolving infection on antibiotics | CRP falls first (half-life 19h); ESR may stay elevated for weeks |